Search Orphan Drug Designations and Approvals
-
| Generic Name: | sleeping beauty transposon-engineered autologous plasmablasts for expression and delivery of iduronate-2-sulfatase |
|---|---|
| Date Designated: | 10/16/2025 |
| Orphan Designation: | treatment of mucopolysaccharidosis type II |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Immusoft CA, Inc. 1700 Owens Street, Unit B San Francisco, California 94158 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







